AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT03678415 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Community-Based Primary Mental Health Care (CBPMHC) package
Description: According to the intervention package, after receiving training, the service providers will start providing service according to learning to the enrolled mothers. The intervention package has developed in many maternal and psychosocial supports like psycho-educational communication about pregnancy complications, danger signs, birth preparedness; psycho-social support including information about psycho-education, graded activities and different types of alternative thoughts. Besides, in this regard the investigators included anxiety and depression disorders symptoms, postpartum mood disorders like postpartum blue, postpartum psychosis, etc. The primary healthcare service provider's provide intervention along with their daily routine and investigators follow it up by their visits.
Study NCT03132415 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Get Connected
Description: The investigators designed the intervention to help participants increase their HIV risk awareness, promote self-appraisal and increase motivation for engaging in prevention services, problem solving barriers to accessing care, and locating culturally-sensitive providers. Intervention content is customized based on participants' socio-demographic characteristics, HIV/STI testing history and testing motivations, and recent sexual behaviors.
Study NCT03132415 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: HIV Test Locator
Description: The investigators will use a HIV/STI testing locator as the attention-control condition. The test locator provides a list of HIV testing sites in a city or zipcode.
Study NCT01304134 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxycodone
Description: dosage:10mg/l dosage form:injection frequency:via PCA pump, background rate:0.5ml/h, 2ml/time duration:48 hours
Study NCT01304134 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Morphine
Description: dosage: 10mg/ml dosage form: injection frequency: via PCA pump, background rate: 0.5ml/h, 2ml/times duration: 48 hours
Study NCT04156386 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Recovery animal (20g whey) protein supplement
Description: Animal protein supplement consumed post exercise to aid recovery of muscle function following strenuous exercise.
Study NCT04156386 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Recover vegan (26g pea) protein supplement
Description: Vegan protein supplement consumed post exercise to aid recovery of muscle function following strenuous exercise.
Study NCT04156386 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo (32g maltodextrin)
Description: Placebo consumed post exercise to aid recovery of muscle function following strenuous exercise.
Study NCT02930681 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Glucosanol 500mg
Study NCT02930681 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Placebo
Study NCT02930681 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT04026750 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Pitolisant
Description: Pitolisant will be administered orally for 7 days. Patients may have their study drug dose adjusted downward if the starting dose is not tolerated.
Study NCT04026750 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pitolisant
Description: Pitolisant will be administered orally for 7 days. Patients may have their study drug dose adjusted downward if the starting dose is not tolerated.
Study NCT04761757 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Booklet of Scripts of Doctors
Description: The Booklet of Scripts for Doctors was used in the control arm. This tool was developed and tested to encourage shared decision-making in prescribing antidepressants within the Malaysian context.
Study NCT04761757 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Booklet of Scripts for Doctors and the Antidepressant Decision Aid for Major depressive disorder patients (ADAM)
Description: The Booklet of Scripts for Doctors along with the Antidepressant Decision Aid for Major depressive disorder patients, ADAM, was used in the intervention arm. The decision aid was developed as per the International Patient Decision Aid Standards (IPDAS) criteria to enhance patient understanding of risks and benefits of different antidepressants available within the Malaysian context.
Study NCT01005784 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cetrorelix (Cetrotide)
Description: flexible antagonist administration according to specified criteria
Study NCT01005784 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cetrorelix (Cetrotide)
Description: fixed antagonist administration on day 6 of ovarian stimulation
Study NCT01579669 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Use of toolkit
Description: Patient participants will be given access to the toolkit and will create a customized report for their provider. Team will send report to providers and ask them to schedule appointment with patient to discuss.
Study NCT01455584 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HM781-36B tablets
Description: Q1X28D/4W for HM781-36B tablets
Study NCT00041197 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: imatinib mesylate
Description: Given orally (PO)
Study NCT00041197 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: Given PO
Study NCT00041197 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: laboratory biomarker analysis
Description: Correlative studies
Study NCT00041197 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: laboratory biomarker analysis
Description: Correlative studies
Study NCT04302207 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: De-implementation Strategy for Bronchiolitis
Description: De-implementation strategy to reduce over-use of treatments for patients with bronchiolitis
Study NCT03444259 — intervention group
Intervention type: PROCEDURE
Intervention: Cardiac surgery
Description: Open heart surgery
Study NCT02384538 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ABT-981
Description: ABT-981 administered by subcutaneous injection
Study NCT02384538 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo for ABT-981
Description: Placebo for ABT-981 administered by subcutaneous injection
Study NCT01023347 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Paclitaxel (Genexol®)
Study NCT01023347 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel loaded polymeric micelle (Genexol-PM®)
Study NCT02916953 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AGN1 Femoral Local Osteo-Enhancement Procedure
Description: A procedure that is intended to increase the strength of the proximal femur in individuals with osteoporosis of the femoral neck. Local treatment of the proximal femur with AGN1 is intended to be adjunctive to appropriate systemic therapy and overall osteoporosis management as directed by the patient's treating physicians.
Study NCT05314829 — intervention group
Intervention type: OTHER
Intervention: Trauma-focused cognitive behavioral therapy (TF-CBT)
Description: TF-CBT is a phase-based evidence-based treatment method for children and adolescents between 6-18 years who experience posttraumatic stress symptoms following trauma exposure. Parents or other close caregivers receive parallel sessions. It is normally provided through 12-16 sessions.
Study NCT01839071 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: biopsy
Study NCT04059289 — intervention group
Intervention type: OTHER
Intervention: Posterior chamber intraocular lens (IOL)
Description: This is NOT an interventional study; the intervention (surgical procedure) has been performed PRIOR to the inclusion in this study
Study NCT02047435 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Information, event and workshops at a cartoon museum
Description: 1. An event at the Storm P. Museum consisting of:~   * A guided tour at the museum~  * A representative from the municipal DaneAge Association will tell about the municipality's activities for the elderly.~  * The museum serves a refreshment and offer participants a season pass to the museum.~   And~2. Workshops at The Storm P. museum, for up to 12 months with approximately two workshops a months. In collaboration with the museum the participants create memory material for nursing home resident with dementia. The workshop will use narrative as a method to give participants a mutual relationship that is perceived as meaningful and rewarding for each participant and in the dialogues a mutual understanding is created. The museum staff facilitates the process of storytelling using events, significant stories and artistic works by Storm P., to encourage the participants, via the method known as narrative interview, to share similar stories from their life.
Study NCT02047435 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Information and event at a cartoon museum
Description: 1. An event at the Storm P. Museum consisting of:~* A guided tour at the museum~* A representative from the municipal DaneAge Association will tell about the municipality's activities for the elderly.~* The museum serves a refreshment and offer participants a season pass to the museum.
Study NCT04215796 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ReX-C system
Description: CFTR modulators are dispensed to patients via ReX-C system
Study NCT02256917 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Human cl rhFVIII
Study NCT03187184 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: OneOme RightMed®
Description: OneOme RightMed® currently tests for 22 genes that impact over 340 drugs used in multiple fields of medicine, including oncology. The drugs tested for by OneOme RightMed® were generated from practice guidelines and the FDA's guidelines for genotyping, and drugs with published, clinical evidence supporting genotyping. Testing is done using a prepackaged OneOme RightMed® kit to collect a buccal swab. OneOme RightMed® PGx test uses a DNA Genotek ORAcollect OC-100 buccal swab kit to extract DNA, which is then analyzed through polymerase chain reaction (PCR).
Study NCT00346762 — intervention group
Intervention type: BEHAVIORAL
Intervention: Education
Description: HIV prevention education and risk reduction counselig
Study NCT00137787 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ciprofloxacin
Study NCT00137787 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: cefepime
Study NCT01620541 — intervention group
Intervention type: PROCEDURE
Intervention: Ankle Arthrodesis
Description: All surgeons will employ a well-established technique of rigid internal fixation. In this technique, the joint is prepared by removing cartilage from the surfaces, the bones are positioned as desired, and screws and/or a plate are attached to compress the bones together and prevent motion. This technique obviates the need for a cast or external support. Patients are allowed to walk with weight bearing aids immediately. Radiographs are performed at 6 weeks to determine weight bearing status. Weight is allowed on the limb in increments over the 6 to 12 weeks after surgery.
Study NCT01620541 — intervention group
Intervention type: PROCEDURE
Intervention: Ankle Arthroplasty
Description: Protocols are similar among participating centers. Each surgeon uses an anterior surgical approach between the tibialis anterior tendon and the toe extensor group, splints the ankles for 2 weeks, and restricts weight bearing for the first 6 weeks. Radiographs are performed at 6 weeks to determine weight bearing status. The study involves only FDA approved implants with which the surgeon has established experience.
Study NCT01773629 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intervention
Description: Participants in the intervention arm will receive standard care plus the addition of a care manager. Care managers will function to provide culturally competent and linguistically appropriate support for the care of women identified as being at high risk for depression in pregnancy. Working with both the care providers and these study participants care managers will serve as connectors, coaches, collaborators, and negotiators working to overcome barriers to depression care delivery.
Study NCT01773629 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Control
Description: Standard of care: within the current care processes, a woman initiating prenatal care completes a depression risk assessment using a two-step approach. Women with high risk of depression are then scheduled for a separate visit with a member of the care team (a physician, psychologist, or other mental health provider) referred to as a perinatal depression champion for a timely formal diagnostic interview.
Study NCT01401946 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: soy isoflavones
Study NCT01401946 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT00629759 — intervention group
Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: JX-594: Recombinant vaccinia virus (TK-deletion plus GM-CSF)
Description: The total dose is divided between 1-3 tumors located within the liver. Patients are treated with JX-594 once every 3 weeks until progression at the site(s) of injection or until the patient has received a maximum of 4 treatments.
Study NCT02727699 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Xanamem™
Description: Xanamem™ is formulated in green and cream coloured size 3, Coni-Snap shaped gelatin capsules as an excipient blend at a dose of 10mg. It contains active pharmaceutical ingredient of UE2343
Study NCT02727699 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo (for Xanamem™)
Description: Excipient blend capsules manufactured to mimic Xanamem™ capsules
Study NCT04314401 — intervention group
Intervention type: PROCEDURE
Intervention: Biospecimen Collection
Description: Undergo collection of blood, tissue, bone marrow, and cerebral spinal fluid samples
Study NCT04870632 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Education
Description: COPD patients conduct pulmonary rehabilitation for 6 weeks by read an education booklet with words and pictures which is made by the physiotherapist.
Study NCT04870632 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Video-based pulmonary rehabilitation
Description: COPD patients conduct pulmonary rehabilitation for 6 weeks by watching Youtube videos which were made by the physiotherapist.The patients are monitored by the physiotherapist by weekly phone call and asked to record RPE scores at the RPE form.
Study NCT04870632 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Booklet-based pulmonary rehabilitation
Description: COPD patients conduct pulmonary rehabilitation for 6 weeks by read an education booklet with words and pictures which is made by the physiotherapist.The patients are monitored by the physiotherapist by weekly phone call and asked to record RPE scores at the RPE form.
Study NCT02609386 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: IRX-2
Description: Method of Administration: Administered for 10 days as subcutaneous bilateral injections in the upper neck.
Study NCT02609386 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Method of Administration: Cyclophosphamide is administered once by IV
Study NCT02609386 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cyclophosphamide
Description: Method of Administration: Cyclophosphamide is administered once by IV
Study NCT04314401 — intervention group
Intervention type: OTHER
Intervention: Medical Chart Review
Description: Medical charts are reviewed and data is collected
Study NCT04134260 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Apalutamide
Description: Given PO
Study NCT04134260 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Hormone Therapy
Description: Receive hormone therapy
Study NCT04134260 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hormone Therapy
Description: Receive hormone therapy
Study NCT04134260 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Quality-of-Life Assessment
Description: Ancillary studies
Study NCT04134260 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quality-of-Life Assessment
Description: Ancillary studies
Study NCT04134260 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT04134260 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT04134260 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Radiation Therapy
Description: Undergo pelvis and prostate bed radiation therapy
Study NCT04134260 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiation Therapy
Description: Undergo pelvis and prostate bed radiation therapy
Study NCT04312802 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Cardiopulmonary exercise test (CPET)
Description: The participant will undergo a cardio-pulmonary exercise test (CPET) on a cycle ergometer (Ergoline) connected to a 12-lead electrocardiogram, oxygen saturation monitor and continuous non-invasive blood pressure cuff. Respiratory gas exchanged will be measured from a tight fitting facemask. An initial 2-min period of baseline data will be collected at rest before a 180-s period of unloaded cycling. A ramp protocol will then be applied and the participant will be instructed to continue cycling at a constant cadence of 60 rpm as long as they can. The test will be terminated if the participant indicates that:~* they cannot continue~* cadence falls to \<55 rpm due to fatigue or dyspnoea~* they develop abnormal cardiac signs or symptoms, such as ischaemia and arrhythmia.
Study NCT04062305 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Hand Function Test
Description: Complete tasks that test grip strength, pinch strength, and ability to use and feel with hands
Study NCT04062305 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Navigated Transcranial Magnetic Stimulation
Description: Undergo nTMS
Study NCT04062305 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quality-of-Life Assessment
Description: Ancillary studies
Study NCT04062305 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT03175029 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TAC-302
Description: TAC-302 200 mg administered orally twice per day after meals, for 12 weeks.
Study NCT03175029 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo administered orally twice per day after meals, for 12 weeks.
Study NCT04089371 — intervention group
Intervention type: DEVICE
Intervention: ReUnion Total Shoulder Arthroplasty (TSA)
Description: The ReUnion RFX System includes a Reversible Fracture Stem (RFX Stem) that can utilize either the ReUnion Total Shoulder Arthroplasty (TSA) or ReUnion Reverse Shoulder Arthroplasty (RSA) humeral and glenoid components and is indicated for use as a hemi, total or reverse shoulder replacement. The ReUnion RFX stem is intended for cemented use only.
Study NCT04089371 — intervention group
Intervention type: DEVICE
Intervention: ReUnion Reverse Shoulder Arthroplasty (RSA)
Description: The ReUnion RFX System includes a Reversible Fracture Stem (RFX Stem) that can utilize either the ReUnion Total Shoulder Arthroplasty (TSA) or ReUnion Reverse Shoulder Arthroplasty (RSA) humeral and glenoid components and is indicated for use as a hemi, total or reverse shoulder replacement. The ReUnion RFX stem is intended for cemented use only.
Study NCT04197921 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Exablate Model 4000 Type 2.0/2.1
Description: There are two treatment stages. In both stages, the subject will receive both the sham and active ExAblate treatment, and be evaluated for 90 days post-treatment for adverse events. During Stage 1 the subject will receive the moderate intensity Exablate LIFU procedure. During Stage2, the subject will receive the enhanced intensity ExAblate LIFU procedure. The subjects are blinded as to the order of the sham vs active treatment.
Study NCT04142437 — intervention group
Intervention type: DRUG
Intervention: larotrectinib(Vitrakvi, BAY2757556)
Description: In the study, patients treated under local standard of care clinical practice; all decisions in terms of diagnostic procedures, treatments, management of the disease, and resource utilization are fully dependent on mutual agreement between the patient and the attending physician, without interference by the study initiator or study protocol
Study NCT02312557 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Enzalutamide
Description: Given PO
Study NCT02312557 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies
Study NCT02312557 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Given IV
Study NCT05838183 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: The relationship between imaging and ROSE and NGS
Description: The correlation between ROSE and NGS in imaging and bronchoscopy of ILD patients was observed
Study NCT02609386 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Indomethacin
Description: Method of Administration: Indomethacin is administered orally for 21 days.
Study NCT02609386 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Indomethacin
Description: Method of Administration: Indomethacin is administered orally for 21 days.